dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Bauer, Sebastian |
dc.contributor.author | Heinrich, Michael C. |
dc.contributor.author | Serrano Garcia, César |
dc.contributor.author | Gelderblom, Hans |
dc.contributor.author | George, Suzanne |
dc.contributor.author | Zalcberg, John |
dc.date.accessioned | 2022-06-27T12:15:35Z |
dc.date.available | 2022-06-27T12:15:35Z |
dc.date.issued | 2021-12-01 |
dc.identifier.citation | Bauer S, Heinrich MC, George S, Zalcberg JR, Serrano C, Gelderblom H, et al. Clinical activity of ripretinib in patients with advanced gastrointestinal stromal tumor harboring heterogenous KIT/PDGFRA mutations in the phase 3 INVICTUS study. Clin Cancer Res. 2021 Dec 1;27(23):6333–42. |
dc.identifier.issn | 1557-3265 |
dc.identifier.uri | https://hdl.handle.net/11351/7733 |
dc.description | Ripretinib; Mutacions; Neoplàsies gastrointestinals |
dc.language.iso | eng |
dc.publisher | American Association for Cancer Research |
dc.relation.ispartofseries | Clinical Cancer Research;27(23) |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ |
dc.source | Scientia |
dc.subject | Aparell digestiu - Càncer - Tractament |
dc.subject | Mutació (Biologia) |
dc.subject | Avaluació de resultats (Assistència sanitària) |
dc.subject.mesh | Gastrointestinal Stromal Tumors |
dc.subject.mesh | /drug therapy |
dc.subject.mesh | Mutation |
dc.subject.mesh | Treatment Outcome |
dc.title | Clinical Activity of Ripretinib in Patients with Advanced Gastrointestinal Stromal Tumor Harboring Heterogeneous KIT/PDGFRA Mutations in the Phase III INVICTUS Study |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1158/1078-0432.CCR-21-1864 |
dc.subject.decs | tumores del estroma gastrointestinal |
dc.subject.decs | /farmacoterapia |
dc.subject.decs | mutación |
dc.subject.decs | resultado del tratamiento |
dc.relation.publishversion | https://doi.org/10.1158/1078-0432.CCR-21-1864 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Bauer S] Department of Medical Oncology, West German Cancer Center, University Hospital Essen, University Duisburg-Essen, Essen, Germany. German Cancer Consortium (DKTK), Partner Site University Hospital Essen, Essen, Germany. [Heinrich MC] VA Portland Veterans Health Care System, Portland, Oregon. OHSU Knight Cancer Institute, Portland, Oregon. [George S] Dana-Farber Cancer Institute, Boston, Massachusetts. [Zalcberg JR] Monash University School of Public Health and Preventive Medicine and Alfred Health, Melbourne, Victoria, Australia. [Serrano C] Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. [Gelderblom H] Leiden University Medical Center, Leiden, the Netherlands |
dc.identifier.pmid | 34503977 |
dc.identifier.wos | 000726492200001 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |